You are here

Children’s Hospital Colorado

13123 East 16th Avenue
Aurora, CO 80045
United States

Most children diagnosed with cancer today will be cured. Unfortunately for some with very difficult-to-treat cancers, standard therapy is ineffective. The Experimental Therapeutics Program (ETP) within the Center for Cancer and Blood Disorders at Children's Hospital Colorado was created to support the development of and enhance the access to the most promising new therapies for children, adolescents and young adults.

“We have been able to offer promising treatments to the children and families who need them most. There are kids who are alive today who would not be without the treatment that we were able to offer.” - Lia Gore, MD

The majority of children diagnosed with cancer in the US are cured with modern, intensive treatment strategies. However despite this good outcome for most patients, a proportion will do very poorly, and have little hope for a cure. As such, novel approaches to therapy and new drugs are clearly needed for these patients. There has been an explosion in the research and development of treatments for cancer in recent years, but unfortunately, moving these agents to pediatric patients has been slow.

I had the privilege of caring for a young cancer patient who first came to us when she was 3 ½ years old. Her doctors felt there was nothing more they could offer her for her T-cell leukemia as she had already received the most aggressive, state-of-the-art care and still her leukemia had come back. Her family became aware of a new drug that we had in a phase I trial, but the study had primarily enrolled adults.